Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor
- PMID: 21723689
- DOI: 10.1016/j.ejso.2011.05.014
Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor
Abstract
Aims: To analyse patient survival after the resection of lung metastases from colorectal carcinoma and specifically to verify whether presence of liver metastasis prior to lung metastasectomy affects survival.
Methods: All patients who, between 1998 and 2008, underwent lung metastasectomy due to colorectal cancer were included in the study. Kaplan-Meier survival analysis was performed with the log-rank test and Cox regression multivariate analysis.
Results: During this period, 101 metastasectomies were performed on 84 patients. The median age of patients was 65.4 years, and 60% of patients were male. The 30-day mortality rate was 2%, and incidence of complications was 7%. The overall survival was 72 months, with 3-and 5-year survival rates of 70% and 54%, respectively. A total of 17 patients (20%) had previously undergone resection of liver metastasis. No significant differences were found in the distribution of what were supposed to be the main variables between patients with and without previous hepatic metastases. Multivariate analysis identified the following statistically significant factors affecting survival: previous liver metastasectomy (p = 0.03), tumour-infiltrated pulmonary lymph nodes (p = 0.04), disease-free interval ≥ 48 months (p = 0.03), and presence of more than one lung metastasis (p < 0.01). In patients with previous liver metastasis, the shorter the time between primary colorectal surgery and the hepatectomy, the lower the survival rate after pulmonary metastasectomy (p = 0.048).
Conclusions: A previous history of liver metastasis shortens survival after lung metastasectomy. The time between hepatic resection and lung metastasectomy does not affect survival; however, patients with synchronous liver metastasis and colorectal neoplasia have poorer survival rates than those with metachronous disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.J Am Coll Surg. 2006 Mar;202(3):468-75. doi: 10.1016/j.jamcollsurg.2005.11.008. Epub 2006 Jan 18. J Am Coll Surg. 2006. PMID: 16500252
-
Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.Ann Thorac Surg. 2006 Jul;82(1):254-60. doi: 10.1016/j.athoracsur.2006.02.027. Ann Thorac Surg. 2006. PMID: 16798225
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017. Ann Thorac Surg. 2004. PMID: 15223436 Review.
-
Histopathologic prognostic factors in resected colorectal lung metastases.Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283. doi: 10.1016/j.athoracsur.2004.06.096. Ann Thorac Surg. 2005. PMID: 15620957 Review.
-
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].Chir Ital. 2005 Sep-Oct;57(5):555-70. Chir Ital. 2005. PMID: 16241086 Italian.
Cited by
-
The management of the advanced colorectal cancer: management of the pulmonary metastases.J Thorac Dis. 2013 Sep;5 Suppl 4(Suppl 4):S383-8. doi: 10.3978/j.issn.2072-1439.2013.06.23. J Thorac Dis. 2013. PMID: 24102011 Free PMC article. Review.
-
Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.World J Surg. 2018 Apr;42(4):1171-1179. doi: 10.1007/s00268-017-4265-3. World J Surg. 2018. PMID: 28948336
-
Insurance Status and Hospital Payer Mix Are Linked With Variation in Metastatic Site Resection in Patients With Advanced Colorectal Cancers.Dis Colon Rectum. 2016 Nov;59(11):1047-1054. doi: 10.1097/DCR.0000000000000684. Dis Colon Rectum. 2016. PMID: 27749480 Free PMC article.
-
Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis.World J Surg Oncol. 2016 Jul 29;14(1):201. doi: 10.1186/s12957-016-0940-3. World J Surg Oncol. 2016. PMID: 27473725 Free PMC article.
-
KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.Br J Cancer. 2015 Feb 17;112(4):720-8. doi: 10.1038/bjc.2014.499. Br J Cancer. 2015. PMID: 25688918 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical